Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT-guided PCI with prasugrel or ticagrelor monotherapy in NSTE-ACS
NL-OMON55165Phase 2Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prasugrel, ticagrelor in acute coronary syndrome (ACS), non–ST-segment elevation acute coronary syndrome (NSTE-ACS), sponsored by Amsterdam University Medical Center. Started Mar 2021; status: active, not recruiting.
02
Drugs
prasugrelticagrelor
03
Conditions
acute coronary syndrome (ACS)non–ST-segment elevation acute coronary syndrome (NSTE-ACS)
Beyond the preview
Go deeper on NL-OMON55165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55165.